semaglutide cardiovascular news HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Oral semaglutide demonstrates a 14%

In a recent update on Eli Lillys Phase 3 clinical studies investigating retatrutidea GIP, GLP-1, and glucagon triple-hormone receptor agonistthe company reported that long-term use achieved substantial weight reduction, improved blood glucose markers, and reduced osteoarthritis-related pain in overweight and obese adults

In a March 10 update on the status of the medications, the U.S

To address this, we developed a chimeric GLP-1A that targets transporter-mediated endocytosis to enhance cellular permeability to GLP-1A by utilizing the transporters available in the intestine, particularly the apical sodium-dependent bile acid transporter (ASBT)

The NHS advises adults to eat no more than 6g of salt a day, which is about one level teaspoon, and most of that already comes from everyday packaged foods

Louisianas 2026 individual market rate filings came in with a weighted-average increase of around 21.9% across all carriers, later revised upward to 23.4%, the largest annual increase the state has seen in years